Article Details
Retrieved on: 2021-09-02 22:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A Roche drug that failed as a treatment for neurological disorders is now the lead program for Disc Medicines. CEO John Quisel said Roche's clinical data ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here